Additionally, TREM2 or TYROBP loss of function mutations result in Nasu-Hakola disease (NHD), also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), characterized by microglial activation and dementia. The gene discussed is TYROBP; the disease is Nasu-Hakola disease.